Steris Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Public

  • Employees
  • 18,179

Employees

  • Stock Symbol
  • STE

Stock Symbol

  • Investments
  • 34

  • Share Price
  • $219.34
  • (As of Friday Closing)

Steris General Information

Description

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Contact Information

Website
www.steris.com
Formerly Known As
Innovative Medical Technologies, Steris Ltd, New Steris Ltd
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 70 Sir John Rogerson's Quay
  • Dublin D02 R296
  • Ireland
+353 (01)
Primary Industry
Distributors (Healthcare)
Other Industries
Other Devices and Supplies
Medical Supplies
Stock Exchange
NYS
Vertical(s)
Corporate Office
  • 70 Sir John Rogerson's Quay
  • Dublin D02 R296
  • Ireland
+353 (01)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Steris Stock Performance

As of 14-Feb-2025, Steris’s stock price is $219.34. Its current market cap is $21.6B with 98.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$219.34 $219.23 $197.82 - $248.24 $21.6B 98.7M 531K $4.72

Steris Financials Summary

As of 31-Dec-2024, Steris has a trailing 12-month revenue of $5.4B.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 22,534,871 25,541,540 21,994,472 27,360,200
Revenue 5,398,371 5,138,701 4,536,266 4,223,403
EBITDA 1,371,811 1,401,362 1,343,998 1,003,113
Net Income 467,592 378,239 107,030 243,888
Total Assets 10,008,362 11,063,697 10,821,839 11,423,594
Total Debt 2,319,893 3,383,167 3,248,277 3,279,884
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Steris Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Steris‘s full profile, request access.

Request a free trial

Steris Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. Th
Distributors (Healthcare)
Dublin, Ireland
18,179 As of 2024

Minneapolis, MN
 

Bad Homburg v.d. Höhe, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Steris Competitors (19)

One of Steris’s 19 competitors is Medtronic, a Corporation company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtronic Corporation Minneapolis, MN
Fresenius Medical Care Corporation Bad Homburg v.d. Höhe, Germany
Henry Schein Corporation Melville, NY
Dentsply Sirona Formerly PE-Backed Charlotte, NC
Becton, Dickinson and Company Corporation Franklin Lakes, NJ
You’re viewing 5 of 19 competitors. Get the full list »

Steris Patents

Steris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1058848-S1 Sterilization cart Active 08-Sep-2023
US-D1058849-S1 Remote device for sterilization cart Active 08-Sep-2023
US-20250026522-A1 Sterilization packaging Pending 21-Jul-2023
EP-4410231-A1 Lighting device Pending 02-Feb-2023
EP-4411212-A1 Lighting device Pending 02-Feb-2023 F21V5/06
To view Steris’s complete patent history, request access »

Steris Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Steris Investments & Acquisitions (34)

Steris’s most recent deal was a Corporate Asset Purchase with Oakmont Business Partners II (35,000-Square-Foot Facility in Concord, North Carolina) for . The deal was made on 01-Aug-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oakmont Business Partners II (35,000-Square-Foot Facility in Concord, North Carolina) 01-Aug-2024 Corporate Asset Purchase Buildings and Property
Cr Kennedy (Customer Contracts And Inventory) 14-Dec-2023 Merger/Acquisition Diagnostic Equipment
Becton, Dickinson and Company (Surgical Instrumentation Platform) 03-Aug-2023 Corporate Asset Purchase Buildings and Property
Synergy Health 17-May-2022 Merger/Acquisition Other Healthcare Services
Cantel Medical 02-Jun-2021 Merger/Acquisition Surgical Devices
You’re viewing 5 of 34 investments and acquisitions. Get the full list »

Steris ESG

Risk Overview

Risk Rating

Updated January, 17, 2025

23.17 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Healthcare

Industry

of 587

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view Steris’s complete esg history, request access »

Steris Exits (4)

Steris’s most recent exit was on 06-Apr-2016 from Servizi Italia. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Servizi Italia 06-Apr-2016 Completed
Controlled Environment Certification Services 01-Dec-2015 Completed
Servizi Italia 31-Oct-2014 Completed
Isotron 20-Jul-1999 Merger/Acquisition Completed
To view Steris’s complete exits history, request access »

Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Dana Products Franklin Park, IL 2002
Key Surgical Eden Prairie, MN 1988
Medisafe UK Bishop's Stortford, United Kingdom 1985
Eschmann Holdings Lancing, United Kingdom 1830

Steris FAQs

  • When was Steris founded?

    Steris was founded in 1985.

  • Where is Steris headquartered?

    Steris is headquartered in Dublin, Ireland.

  • What is the size of Steris?

    Steris has 18,179 total employees.

  • What industry is Steris in?

    Steris’s primary industry is Distributors (Healthcare).

  • Is Steris a private or public company?

    Steris is a Public company.

  • What is Steris’s stock symbol?

    The ticker symbol for Steris is STE.

  • What is the current stock price of Steris?

    As of 14-Feb-2025 the stock price of Steris is $219.34.

  • What is the current market cap of Steris?

    The current market capitalization of Steris is $21.6B.

  • What is Steris’s current revenue?

    The trailing twelve month revenue for Steris is $5.4B.

  • Who are Steris’s competitors?

    Medtronic, Fresenius Medical Care, Henry Schein, Dentsply Sirona, and Becton, Dickinson and Company are some of the 19 competitors of Steris.

  • What is Steris’s annual earnings per share (EPS)?

    Steris’s EPS for 12 months was $4.72.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »